Nanophoria Bioscience
CONTACT
  • About us
    • About NanoPhoria
    • Team
    • Investors
  • Therapeutic focus
  • Our Platform
    • Drug Delivery Platform
    • Pipeline
    • Background Science
  • Clinical Programs
    • NP-MP1
  • News
    • Press releases

Month: January 2026

NanoPhoria Announces Second Close of its Series A Round, Now with Participation from European Innovation Council Fund 

Posted on 12 January 202613 March 2026 by Barnaby Pickering
Posted in Uncategorized

Recent Posts

  • NanoPhoria Announces Second Close of its Series A Round, Now with Participation from European Innovation Council Fund 
  • NanoPhoria Named Startup of the Year by StartupItalia
  • NanoPhoria Bioscience secures €83.5 Million Series A to Advance Breakthrough Heart Failure Therapy and Expand Portfolio for Novel Nano-in-Micro Delivery Platform
  • NanoPhoria Bioscience Awarded €17.5 M From European Innovation Council’s Accelerator Program
  • NanoPhoria appoints Dr Suman Shirodkar as chair and Prof. Michael Davidson as non-executive member of the Board of Directors

Recent Comments

No comments to show.

Archives

  • January 2026
  • December 2025
  • October 2025
  • February 2025
  • January 2024
  • November 2022
  • June 2022
  • May 2022

Categories

  • Uncategorized
Connect with us
Learn more about our company and the science behind our revolutionary technology platform
Get in touch
Terms of use
Privacy Policy
Cookies

© NanoPhoria S.r.l. All rights reserved.
VAT number: 12246020965